Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases

British Journal of Surgery

Volumn 83, Issue 8, 1996, Pages 1144-1147

  Siewert, J R ^a   Kestlmeier, R ^a   Busch, R ^b   Bottcher K ^a   Roder, J D ^a   Muller J ^a   Fellbaum, C ^a   Hofler H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; TOTAL STOMACH RESECTION; LYMPHADENECTOMY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0029662322     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830836     Document Type: Article

References (22)

1. Siewert JR. Böttcher K, Roder JD, Busch R, Hermanek P, Meyer HJ and the German Gastric Carcinoma Study Group. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 1993; 80: 1015-18.
2. Fass J, Hungs M, Rcineke T, Nachtkamp J, Schumpelick V. Zur Frage der Prognoseverbesserung durch R1- und R2-Lymphadenektomic beim Magencarcinoma. Chirurg 1994; 65: 867-72.
3. Gall FP, Hermanek P. Die systematische erweiterte Lympknotendissektion in der kurativen Therapie des Magencarcinoms. Chirurg 1993; 64: 1024-31.
4. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 1981; 11: 127-45.
5. Siewert JR, Lange J, Böttcher K, Becker K, Stier A. Lymphadenektomie heim Magencarcinom. Langenbecks Arch Chir 1986; 368: 137-48.
6. Hermanek P, Sobin LH, eds. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours. 4th ed. Berlin: Springer, 1987.
7. Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 1982; 95: 580-8.
8. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990; 43: 213-19.
9. Momburg F, Moldenhauer G, Hämmerling GJ, Möller P. Immunohistochemical study of the expression of a Mr 34000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 1987; 47: 2883-91.
10. Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-29.
11. Kestlmeier R, Busch R, Fellbaum Ch et al. Prognostic relevance of sarcoid-like lesions and microcarcinosis in lymph nodes in gastric cancer. Pathol Res Pract 1994; 190: 234.
12. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc B 1972; 34: 187-220.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70.
15. Böttcher K, Becker K, Busch R, Roder JD, Siewert JR. Prognosefaktoren beim Magenkarzinom - Ergebnisse einer uni- und multivariaten Analyse. Chirurg 1992; 63: 656-61.
16. Roder JD, Böttcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ and the German Gastric Cancer Study Group (1992). Prognostic factors in gastric carcinoma. Cancer 1993; 72: 2089-97.
17. Adachi Y, Kamakura T, Mori M, Baba H, Maehara Y, Sugimachi K. Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg 1994; 81: 414-16.
18. Ichikura T, Tomimatsu S, Okusa Y, Uefuji K, Tamakuma S. Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol 1993; 11: 1894-1900.
19. Wagner PK, Ramaswamy A, Rüschoff J, Schmitz-Moormann P, Rothmund M. Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 1991; 78: 825-7.
20. McGuckin MA, Wright RG, McKenzie IFC, Ward BG. Demonstration of two ovarian tumor-associated antigens in primary and metastatic breast, gastric, and colonic tumors. Am J Clin Pathol 1990; 94: 137-41.
21. Pugachev KK, Shimbireva IB. Use of a mixture of types of antibodies for immunohistologic detection of stomach cancer micrometastases. Arkh Patol 1991; 53: 66-8.
22. Becker KF, Atkinson MJ, Reich U et al. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum Mol Genet 1993; 2: 803-4.